Liver-targeted delivery of liposome-encapsulated curcumol using galactosylated-stearate

Liver-targeted drug delivery improves the efficacy of anti-liver cancer agents and reduces systemic toxicity by limiting the bioavailability of these drugs to within tumors. Liver targeting reagents with galactose residues, which selectively combine to asialoglyco protein receptors, have previously...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Exp Ther Med
Auteurs principaux: Li, Wen-Jie, Lian, You-Wen, Guan, Quan-Sheng, Li, Ning, Liang, Wen-Jun, Liu, Wen-Xin, Huang, Yong-Bin, Cheng, Yi, Luo, Hui
Format: Artigo
Langue:Inglês
Publié: D.A. Spandidos 2018
Sujets:
Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6090458/
https://ncbi.nlm.nih.gov/pubmed/30112045
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2018.6210
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires